Close Menu

NEW YORK – The Mark Foundation for Cancer Research announced on Monday that it has created the Mark Foundation Center for Advanced Genomics and Imaging at Johns Hopkins University.

The center, which will receive initial funding of $5 million over two years, will bring together pathology, computer science, cancer genomics, and immunogenomics to study oncology. Specifically, the researchers will work to expand the number of cancer patients who benefit from immunotherapy. They will also use tools of astronomy image analysis, the Mark Foundation said.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.

Jul
16

Join this webinar to learn how spatial resolution of gene expression in tumor tissue reveals new insights in biomarker discovery and therapeutic response. 

Jul
23

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.

Aug
25

Non-small cell lung cancer (NSCLC) patients with ALK rearrangements are treated with tyrosine kinase inhibitors (TKIs), which often leads to prolonged overall survival. However, treatment resistance will almost inevitably occur, and the disease remains incurable.